Cargando…

Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?

Detalles Bibliográficos
Autores principales: Chang, Chia‐Hsuin, Chuang, Lee‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031505/
https://www.ncbi.nlm.nih.gov/pubmed/29140602
http://dx.doi.org/10.1111/jdi.12776
_version_ 1783337325676199936
author Chang, Chia‐Hsuin
Chuang, Lee‐Ming
author_facet Chang, Chia‐Hsuin
Chuang, Lee‐Ming
author_sort Chang, Chia‐Hsuin
collection PubMed
description
format Online
Article
Text
id pubmed-6031505
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60315052018-07-11 Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin? Chang, Chia‐Hsuin Chuang, Lee‐Ming J Diabetes Investig Commentaries John Wiley and Sons Inc. 2017-12-15 2018-07 /pmc/articles/PMC6031505/ /pubmed/29140602 http://dx.doi.org/10.1111/jdi.12776 Text en © 2017 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentaries
Chang, Chia‐Hsuin
Chuang, Lee‐Ming
Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
title Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
title_full Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
title_fullStr Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
title_full_unstemmed Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
title_short Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
title_sort cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: is there a better basal insulin?
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031505/
https://www.ncbi.nlm.nih.gov/pubmed/29140602
http://dx.doi.org/10.1111/jdi.12776
work_keys_str_mv AT changchiahsuin cardiovascularsafetyoflongactinginsulinanalogsintype2diabetespatientsisthereabetterbasalinsulin
AT chuangleeming cardiovascularsafetyoflongactinginsulinanalogsintype2diabetespatientsisthereabetterbasalinsulin